1 year return (CAGR)
152.19%
Renovaro Biosciences Inc Exchange (NASDAQ, USD)
RENB
-
-0.35 (-2.69%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-14.42%
5 year return (CAGR)
-18.77%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
292.36M
Price/Sales
-
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 12.80 |
| Daily high | 13.54 |
| Daily low | 12.14 |
| Daily Volume | 297K |
| 1y analyst estimate | - |
| Beta | 0.53 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RENB | S&P500 | |
| Current price drop from All-time high | -99.01% | -0.29% |
| Highest price drop | -99.87% | -56.47% |
| Date of highest drop | 22 Sep 2025 | 9 Mar 2009 |
| Avg drop from high | -59.77% | -10.68% |
| Avg time to new high | 59 days | 12 days |
| Max time to new high | 961 days | 1805 days |
News
No items found